MTEM insider filings

Molecular Templates, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-11-18. Screen MTEM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MTEM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Molecular Templates, Inc.

FiledFormInsiderReported transactionsSource
2024-11-184BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Sale (S): 1,279,820 @ $0.66 · Purchase (P): 134,667 (derivative) @ $2.35 · Purchase (P): 769,334 (derivative) @ $0.12EDGAR
2024-09-304LALANDE KEVIN M. — Director, 10% ownerGrant/award (A): 1,000 (derivative) @ $0EDGAR
2024-09-304Gruia Gabriela — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2024-09-304SELICK HAROLD E — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2024-09-304HOFFMANN DAVE — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2024-09-304Sanders Corazon (Corsee) D. — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2024-04-044LALANDE KEVIN M. — Director, 10% ownerGrant/award (A): 175,000 @ $2.35 · Grant/award (A): 402,077 (derivative) @ $2.35 · Grant/award (A): 1,154,154 (derivative) @ $0.12EDGAR
2024-04-044BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 250,000 @ $2.35 · Purchase (P): 134,667 (derivative) @ $2.35 · Purchase (P): 769,334 (derivative) @ $0.12EDGAR
2024-01-254Voi Maurizio — Chief Medical OfficerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-01-254Kim Jason S. — Chief Financial OfficerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-01-254Poma Eric E — See remarks, DirectorGrant/award (A): 23,333 (derivative) @ $0EDGAR
2023-11-014Voi Maurizio — Chief Medical OfficerGrant/award (A): 11,333 (derivative) @ $0EDGAR
2023-10-314Gruia Gabriela — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2023-10-314HOFFMANN DAVE — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2023-10-314SELICK HAROLD E — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2023-10-314Sanders Corazon (Corsee) D. — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2023-10-314Lanfear Jonathan — DirectorGrant/award (A): 1,000 (derivative) @ $0EDGAR
2023-10-314LALANDE KEVIN M. — Director, 10% ownerGrant/award (A): 1,000 (derivative) @ $0EDGAR
2023-08-314Gruia Gabriela — Interim Chief Medical Officer, DirectorGrant/award (A): 11,666 (derivative) @ $0EDGAR
2023-07-194BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 4,255,319 @ $0.47EDGAR
2023-02-174Poma Eric E — See remarks, DirectorGrant/award (A): 400,000 (derivative) @ $0EDGAR
2023-02-174Waltzman Roger J. — See remarksGrant/award (A): 170,000 (derivative) @ $0EDGAR
2023-02-174Kim Jason S. — See remarksGrant/award (A): 170,000 (derivative) @ $0EDGAR
2022-07-114Kim Jason S. — See remarksOption exercise (M): 12,089 @ $0.71 · Option exercise (M): 12,089 (derivative) @ $0EDGAR
2022-06-214LALANDE KEVIN M. — Director, 10% ownerPurchase (P): 100,000 @ $0.91 · Purchase (P): 60,000 @ $0.87 · Purchase (P): 62,000 @ $0.89EDGAR
2022-06-214SHV Management Services, LLC — 10% owner
Cunningham Joe H — 10% owner
FRENCH DOUGLAS D — 10% owner
SHV Management Services, LP — 10% owner
SHV Annex Services, LP — 10% owner
Sante Health Ventures I Annex Fund, LP — 10% owner
SANTE HEALTH VENTURES I LP — 10% owner
Purchase (P): 100,000 @ $0.91 · Purchase (P): 60,000 @ $0.87 · Purchase (P): 62,000 @ $0.89EDGAR
2022-06-214McLennan Sean — See remarksPurchase (P): 30,000 @ $0.82EDGAR
2022-06-064Sanders Corazon (Corsee) D. — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-064Gruia Gabriela — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-064Lanfear Jonathan — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-064LALANDE KEVIN M. — Director, 10% ownerGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-064HOFFMANN DAVE — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-064Hirsch David — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-064SELICK HAROLD E — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-05-184BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 200,000 @ $1.18EDGAR
2022-04-294Poma Eric E — See remarks, DirectorOption exercise (M): 6,831 @ $0.71 · Option exercise (M): 27,325 @ $0.71 · Option exercise (M): 6,831 (derivative) @ $0 · Option exercise (M): 27,325 (derivative) @ $0EDGAR
2022-03-024Gruia Gabriela — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-02-174Waltzman Roger J. — See remarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-02-174McLennan Sean — See remarksGrant/award (A): 85,000 (derivative) @ $0EDGAR
2022-02-174Poma Eric E — See remarks, DirectorGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-02-174Kim Jason S. — See remarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-104BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 200,000 @ $4.04EDGAR
2021-09-234BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 750,000 @ $6EDGAR
2021-09-204BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 100,000 @ $6.13EDGAR
2021-07-284BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 80,000 @ $7.00 · Purchase (P): 75,000 @ $7.09EDGAR
2021-07-214BIOTECH TARGET N V — 10% owner
BB BIOTECH AG — 10% owner
Purchase (P): 119,382 @ $6.96 · Purchase (P): 125,000 @ $7.13EDGAR
2021-07-074Poma Eric E — See remarks, DirectorOption exercise (M): 3,563 @ $0.71 · Option exercise (M): 3,563 (derivative) @ $0EDGAR
2021-06-294Kim Jason S. — See remarksOption exercise (M): 32,038 @ $0.71 · Sale (S): 2,770 @ $8.36 · Option exercise (M): 32,038 (derivative) @ $0EDGAR
2021-06-044LALANDE KEVIN M. — Director, 10% ownerGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-044Lanfear Jonathan — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR

Recent 8-K events — Molecular Templates, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-04-248-K1.01 — Entry into a Material Definitive Agreement
1.03 — Bankruptcy or Receivership
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2024-12-198-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-12-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-12-048-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-11-268-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2024-10-118-K?EDGAR
2024-10-048-K?EDGAR
2024-09-278-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MTEM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs